PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) randomized phase II study

Steven R. Alberts, N. R. Foster, R. F. Morton, J. Kugler, P. Schaefer, M. Wiesenfeld, T. R. Fitch, P. Steen, G. P. Kim, S. Gill

Research output: Contribution to journal › Article › peer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) randomized phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences